Christopher Bunker

Vice President, Biopharma Business Development · Alamar Biosciences Inc. · company speakers →

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Alzheimer's & Parkinson's Drug Development Summit

3 February 2026 Boston, United States “NULISA Neurology Biomarker Platform – Brain-derived pTau217 & High-plex Neurodegenerative Disease & Neuroinflammatory Biomarker Analysis”

Sourcing speakers for your event?

Browse the speaker directory →